In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma
about
DIPG in Children - What Can We Learn from the Past?Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaDrug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of gliomaPhase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma.Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.Morphine modulates doxorubicin uptake and improves efficacy of chemotherapy in an intracranial xenograft model of human glioblastomaABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model.Novel therapeutic delivery approaches in development for pediatric gliomas.Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.Pediatric high-grade astrocytomas: a distinct neuro-oncological paradigm.Diffuse intrinsic pontine glioma: a reassessment.Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.Managing teenage/young adult (TYA) brain tumors: a UK perspective.Temozolomide resistance and tumor recurrence: Halting the Hedgehog.Preclinical studies of pegylated- and non-pegylated liposomal forms of doxorubicin as radiosensitizer on orthotopic high-grade glioma xenografts.Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas.Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma.Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme.Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates.ATP7B expression in human glioblastoma is related to temozolomide resistance.Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.Prolonged exposure to doxorubicin after radiotherapy in glioblastoma.Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma.Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.Diffuse Intrinsic Pontine Glioma : Clinical Features, Molecular Genetics, and Novel Targeted Therapeutics.Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy.Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
P2860
Q26777843-4AF9D2C8-EEA9-4E74-90BE-5AA791473D9DQ28833173-C0207B98-0087-4F7A-8F12-D8C47A768DDAQ30413487-2AB39BB8-80EF-4EFD-ACB3-B5336420663DQ33423926-384E7BD7-CE28-493B-BF50-AF6B3068208FQ35078800-F554D9E2-3E4A-4B55-ABF5-55D38C6AD9CAQ36853871-C8DB4DF9-8A57-4CD8-8B37-9DAABD7EBF40Q36918220-9EB511C2-8105-47BA-8B11-3A7B936F7C45Q37551759-B9AC80F4-8D2F-4238-926B-54789D3CE6F2Q37668034-2584A766-FFDD-41A7-A9AE-28F74CDB50C1Q37668050-C55B1569-8B61-413E-B7DE-552A4020013AQ38125816-77A38C26-F83C-466D-A890-C8090716562FQ38208998-5984CCF9-144D-480D-9201-793F6F0F50D7Q38363549-712E9549-828A-4D92-859A-E3E815DC839EQ38539466-7F8ABBE8-3547-4294-8057-D1B57BBA760EQ38829499-5B5BDE0D-3FB0-45E8-A6A5-8362190E2C2FQ38973056-8BA96BB5-44F8-485E-9651-57E7FAD162B3Q39217689-A845B027-63A4-4FB2-A3B2-566863BF175BQ39236500-521500D0-79AA-470F-A006-8610947A7391Q40560681-6D93E1D3-F3FC-43D1-A721-4685F23B74F7Q41109977-FE206345-7E99-4727-9879-5A2A76168C21Q42154258-04459358-4A44-4C2A-812A-0320E4DBFE25Q47100454-C3DB06C8-8621-4918-9B77-BAC59290BC19Q47130958-ACF26F01-CEFC-414A-8E4F-CAD5AC67F5E3Q47158930-AA4929CC-8EEA-457F-9362-FDB3426FD8F0Q48245311-3C3D62B1-76B9-4F99-A26C-495B29CDEDFFQ52684145-F5869A02-EFD5-4517-B006-4CD4ECA30C7FQ54313994-BECD9544-2E93-4856-8E18-BFA56AF1AF21Q55285428-B715DBFB-19F8-49FC-846E-4B2EBC0E1B8DQ55456554-CA9C4371-B2B1-4AFE-8DF5-F26266BF115BQ55456951-326BDF15-35C3-47E7-A90C-76BAD089EEFFQ59134092-9E3A771B-C801-4D64-9C0B-5CD6A44ABAC8
P2860
In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@ast
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@en
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@nl
type
label
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@ast
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@en
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@nl
prefLabel
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@ast
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@en
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@nl
P2093
P2860
P1433
P1476
In vitro drug response and eff ...... ffuse intrinsic pontine glioma
@en
P2093
David P Noske
Dennis Biesmans
Esther Hulleman
GertJan J L Kaspers
Ilona Horsman
Laurine E Wedekind
Marc H A Jansen
Susanna J E Veringa
William Peter Vandertop
P2860
P304
P356
10.1371/JOURNAL.PONE.0061512
P407
P577
2013-01-01T00:00:00Z